Both in Pharmaceuticals
Structure Therapeutics vs BeOne Medicines
Over the past year GPCR returned −40.0% and ONC returned +23.6%; their daily moves had a correlation of 0.20.
GPCR −40.0% ONC +23.6%Growth of $1, one year, split-adjusted
| Metric | GPCR | ONC |
|---|---|---|
| Price | $20.35 | $406.96 |
| Market cap | $1.45B | $46.49B |
| Today | +6.66% | +5.09% |
| 1 month | −20.7% | +16.2% |
| 6 months | −48.0% | +30.4% |
| Year to date | −70.7% | +34.0% |
| 1 year | −36.8% | +26.6% |
| Revenue growth (YoY) | — | +29.6% |
| Gross margin | — | 89.8% |
| Net margin | — | 13.9% |
| P/E (TTM) | — | 70.9× |
| Price / sales | — | 7.6× |
| Net cash | $1.34B | $4.02B |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 33.3% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).